Is this the time to introduce minimal residual disease in multiple myeloma clinical practice?

Is this the time to introduce minimal residual disease in multiple myeloma clinical practice?

Item
http://www.wikidata.org/entity/Q28087357
Mcl-1 downregulation leads to the heightened sensitivity exhibited by BCR-ABL positive ALL to induction of energy and ER-stress.Utilizing next-generation sequencing in the management of multiple myeloma.Multiple Myeloma Minimal Residual Disease.Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work.Standardisation of minimal residual disease in multiple myeloma.Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma.High sensitivity blood-based M-protein detection in sCR patients with multiple myeloma.Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.New Perspectives Offered by Nuclear Medicine for the Imaging and Therapy of Multiple Myeloma.Minimal residual disease analysis in myeloma - when, why and where.Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication.
P2860

Is this the time to introduce minimal residual disease in multiple myeloma clinical practice?

Item
http://www.wikidata.org/entity/Q28087357
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Is this the time to introduce ...... ple myeloma clinical practice?
@ast
Is this the time to introduce ...... ple myeloma clinical practice?
@en
Is this the time to introduce ...... ple myeloma clinical practice?
@nl
type
label
Is this the time to introduce ...... ple myeloma clinical practice?
@ast
Is this the time to introduce ...... ple myeloma clinical practice?
@en
Is this the time to introduce ...... ple myeloma clinical practice?
@nl
prefLabel
Is this the time to introduce ...... ple myeloma clinical practice?
@ast
Is this the time to introduce ...... ple myeloma clinical practice?
@en
Is this the time to introduce ...... ple myeloma clinical practice?
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Is this the time to introduce ...... ple myeloma clinical practice?
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-14-2841
P407
P433
P478
P577
P698